DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nebupent (Pentamidine Isethionate) - Published Studies


Nebupent Related Published Studies

Well-designed clinical trials related to Nebupent (Pentamidine)

Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome. [1995]

A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis. [1993]

Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. [1991]

Well-designed clinical trials possibly related to Nebupent (Pentamidine)

Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. [1995]

Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. [1994]

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. [1993]

Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. [1992]

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. [1990]

Other research related to Nebupent (Pentamidine)

Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. [2005]

A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. [2001]

Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. [1999]

Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidine. [1996]

Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group. [1996]

Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus. [1995]

Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. [1995]

Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group. [1995]

Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. [1995]

Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group. [1994]

Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. [1993]

Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. [1993]

Other possibly related research studies

Chemotherapy for second-stage Human African trypanosomiasis. [2010]

Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. [2006]

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. [2005]

Treatment of canine Old World visceral leishmaniasis: a systematic review. [2005]

QT prolongation with antimicrobial agents: understanding the significance. [2004]

Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. [2002]

[Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole]. [Article in French] [1998]

Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. [2000]

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. [2000]

Combining mortality and longitudinal measures in clinical trials. [1999]

Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. [1998]

Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. [1997]

A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. [1996]

Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients. [1996]

AIDS-related spontaneous pneumothorax. Risk factors and treatment. [1995]

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. [1995]

The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. [1995]

Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients. [1995]

Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis. [1994]

Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? [1994]

[Current therapy of trypanosomiasis] [1994]

Chemotherapy for second-stage human African trypanosomiasis. [2013]

Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update. [2013]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017